Neurodegeneration in Newborns After Anesthetics

NCT03064607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2019-02-19

No results posted yet for this study

Summary

The purpose of the study is to quantify biomarkers of neural damage in neonates exposed to varying levels of volatile anesthetic in utero.

Conditions

Interventions

OTHER

Fluid collection

Fluids tested for biomarker S100beta

Sponsors & Collaborators

Principal Investigators

  • Huafeng Wei, MD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-05
Primary Completion
2018-02-06
Completion
2018-02-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03064607 on ClinicalTrials.gov